Event Title
Emerging Treatments in Alzheimer's Disease
Presentation Type
Oral and/or Visual Presentation
Presenter Major(s)
Biomedical Sciences
Mentor Information
Sheldon Kopperl
Department
Biomedical Sciences
Location
Kirkhof Center 2270
Start Date
10-4-2013 12:00 AM
End Date
10-4-2013 12:00 AM
Keywords
Health
Abstract
Alzheimer's disease is a neurodegenerative disease common in the elderly. Some of the symptoms associated with the disease are deterioration of cognitive functions and loss of memory. These result in lowered ability to perform daily functions. For late-stage patients increased symptoms of dementia, including confusion, personality and speech changes, and eventually an almost vegetative state. It is estimated that in 2050 there will be over 16 million people living with Alzheimer's. Due to the large number of people that will be reaching the elderly stage (over 65) in the next few decades, it is important to find an efficient treatment for this disease, since the current therapies do little to help. This presentation will look at emerging treatments in AD. First, it will give background on the disease, its pathology and current treatments. Newer therapies that may open up new treatment pathways will then be the focus.
Emerging Treatments in Alzheimer's Disease
Kirkhof Center 2270
Alzheimer's disease is a neurodegenerative disease common in the elderly. Some of the symptoms associated with the disease are deterioration of cognitive functions and loss of memory. These result in lowered ability to perform daily functions. For late-stage patients increased symptoms of dementia, including confusion, personality and speech changes, and eventually an almost vegetative state. It is estimated that in 2050 there will be over 16 million people living with Alzheimer's. Due to the large number of people that will be reaching the elderly stage (over 65) in the next few decades, it is important to find an efficient treatment for this disease, since the current therapies do little to help. This presentation will look at emerging treatments in AD. First, it will give background on the disease, its pathology and current treatments. Newer therapies that may open up new treatment pathways will then be the focus.